Clinical Trials Logo

Social Anxiety Disorder clinical trials

View clinical trials related to Social Anxiety Disorder.

Filter by:

NCT ID: NCT00273039 Completed - Anxiety Disorders Clinical Trials

A Study Of A New Medicine (GW679769) For The Treatment Of Social Anxiety Disorder

Start date: August 2005
Phase: Phase 2
Study type: Interventional

The purpose of this study is to test the safety and efficacy of GW679769 and paroxetine in subjects with Social Anxiety Disorder

NCT ID: NCT00246441 Completed - Clinical trials for Alcohol Use Disorder

Paroxetine for Comorbid Social Anxiety Disorder and Alcoholism

Start date: March 2002
Phase: Phase 4
Study type: Interventional

The purpose of the study is to determine whether an SSRI, paroxetine, improves social anxiety symptoms and alcohol use in individuals who drink to cope with social anxiety disorder.

NCT ID: NCT00238719 Completed - Clinical trials for Social Anxiety Disorder

Study Evaluating Venlafaxine ER in Children and Adolescents With Social Anxiety Disorder

Start date: December 1999
Phase: Phase 3
Study type: Interventional

To determine the anxiolytic efficacy, safety, and tolerability of a flexible-dose of venlafaxine extended release (ER) administered for 16 weeks in the treatment of children and adolescent outpatients with social anxiety disorder (generalized) in a placebo-controlled study.

NCT ID: NCT00215254 Completed - Clinical trials for Social Anxiety Disorder

Quetiapine in Social Anxiety Disorder

Start date: March 2004
Phase: Phase 2/Phase 3
Study type: Interventional

The purpose of the study is to examine the effectiveness and tolerability of quetiapine for the treatment of social anxiety disorder (SAD). The hypothesis is that quetiapine will be effective and well-tolerated for patients with social anxiety disorder.

NCT ID: NCT00215150 Completed - Clinical trials for Social Anxiety Disorder

Geodon for the Treatment of Refractory Social Anxiety Disorder

SAD
Start date: November 2004
Phase: Phase 2
Study type: Interventional

The purpose of this study is to examine the effectiveness and tolerability of augmentation treatment of ziprasidone to achieve remission among patients with social anxiety disorder (SAD) who did not remit on sertraline treatment alone

NCT ID: NCT00208741 Completed - Clinical trials for Social Anxiety Disorder

Study To Evaluate The Effects Of Gabitrilâ„¢ In Patients With Social Anxiety Disorder

Start date: June 2002
Phase: Phase 4
Study type: Interventional

The main purpose of this study is to determine how safe and effective Gabitril is for outpatients with Social Anxiety Disorder (SAD).

NCT ID: NCT00177008 Completed - Schizophrenia Clinical Trials

Aripiprazole for the Treatment of Schizophrenia With Co-Morbid Social Anxiety

Start date: March 2004
Phase: Phase 4
Study type: Interventional

This study will determine the efficacy of a medication switch to Aripiprazole for the treatment of schizophrenia or schizoaffective disorder in patients with moderate to high symptoms of social anxiety. Specifically the study will test the possibility that a medication switch to Aripiprazole reduces symptoms of social anxiety in this patient population.

NCT ID: NCT00074802 Completed - Clinical trials for Social Anxiety Disorder

Adding Cognitive Behavioral Therapy to Drug Treatment for Social Anxiety Disorder

Start date: December 2003
Phase: Phase 3
Study type: Interventional

This study will determine whether the addition of cognitive behavioral therapy can improve the effectiveness of the medication paroxetine (Paxil®) in treating individuals with social anxiety disorder.